Home / Inspections / 1250223

FDA Inspection 1250223 — New York Blood Center Inc

New York Blood Center Inc — FEI 3005255747

The FDA completed an inspection of New York Blood Center Inc on September 18, 2024 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 18, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Facility

Other inspections at this facility

  • 1103290 (NAI Mon Aug 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 995189 (NAI Mon Dec 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 906933 (NAI Mon Dec 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 815920 (NAI Fri Feb 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 722591 (NAI Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources